![EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target]()
EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic targetIida, K; Nakayama, K; Rahman, M T; Rahman, M; Ishikawa, M; Katagiri, A; Yeasmin, S; Otsuki, Y; Kobayashi, H; Nakayama, S; Miyazaki, K · British Journal of Cancer · 2011